DiscoverMelanoma Insights for ProfessionalsCritical questions for a melanoma pathologist
Critical questions for a melanoma pathologist

Critical questions for a melanoma pathologist

Update: 2022-06-27
Share

Description

The role of pathology in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the pathologist for accurate diagnoses and critical pathological information, we decided to reach out to our clinical melanoma community to ask them for their critical pathology questions. 


In this podcast, Prof John Thompson AO and Prof Fergal Moloney pick at the brain of the world's leading melanoma Pathologist, Prof Richard Scolyer AO, as they discuss: 



  • The clinical information needed to aid diagnosis 

  • The role of artificial intelligence and computing in pathology 

  • Overdiagnosis of melanoma 

  • The problem of partial biopsies 

  • Diagnosing borderline lesions 

  • What is a melanocytoma and how should it be managed 

  • What is an irritated naevus 

  • Dysplastic naevi and appropriate management 


This podcast is suitable for GPs, Dermatologists, Surgeons, Oncologists, Pathologists and other healthcare professionals. 


SPEAKERS 


Prof Richard Scolyer AO - Co-Medical Director, Melanoma Institute Australia | Pathologist, Melanoma Institute Australia, Senior Staff Specialist, Royal Prince Alfred Hospital | Clinical Professor, The University of Sydney 


Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Member, Melanoma Institute Australia 


Prof Fergal Moloney - Consultant Dermatologist, Melanoma Institute Australia and Mater Misericordiae University Hospital | Clinical Professor, University College, Dublin 


Please note that this podcast was accurate at the time of recording (June 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. 


For more practice-changing education, visit our Melanoma Education Portal. 


MIA's Education Program is proudly supported through unrestricted educational grants from: MSD, Bristol Myers Squibb, Novartis and HEINE.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Critical questions for a melanoma pathologist

Critical questions for a melanoma pathologist

Melanoma Institute Australia